Selectively increased oxidative modifications mapped to detergent‐insoluble forms of Aβ and β‐III tubulin in Alzheimer's disease
- 1 July 2006
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 20 (9), 1473-1483
- https://doi.org/10.1096/fj.06-5920com
Abstract
Deleterious post-translational modifications (PTMs) to the neuronal cytoskeleton are a proposed mechanistic link between accumulation of amyloid (A) beta peptides and subsequent abnormalities of tau and neurodegeneration in Alzheimer's disease (AD). Here we tested the hypothesis that PTMs on neuronal tubulins selectively accumulate in a pathological protein fraction in AD. We used new software, P-MOD, to identify comprehensively and map PTMs using mass spectral data from soluble (normal) and detergent-insoluble (pathological) protein fractions from AD, as well as total extracts from controls, for selected proteins: Abeta, tau, apolipoprotein (apo) E, glial fibrillary acidic protein (GFAP), alpha-III tubulin, and beta-III tubulin. Our results confirmed direct observations of others by identifying methionine (M) sulfoxides at Abeta position 35 and numerous sites of tau phosphorylation in detergent-insoluble protein from AD, while no PTMs were enriched on primarily astrocyte-derived apoE or GFAP in this fraction. P-MOD mapped several abundant M sulfoxides to neuron-enriched beta-III tubulin but not its heterodimeric partner, neuron-enriched alpha-III tubulin, a result confirmed by selective suppression of CNBr-mediated cleavage of beta-III tubulin. These findings are the first comprehensive assessment of PTMs in AD and point to oxidative modification of beta-III tubulin as a potential contributor to the neuronal cytoskeletal disruption that is characteristic of AD.Keywords
Funding Information
- Nancy and Buster Alvord Endowment
- National Institutes of Health (AG24011, AG05136, AG022040, AG023483)
This publication has 45 references indexed in Scilit:
- Proteomic determination of widespread detergent insolubility, including Aβ but not tau, early in the pathogenesis of Alzheimer's diseaseThe FASEB Journal, 2005
- Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and LipoxidationJournal of Biological Chemistry, 2005
- Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent‐insoluble paired helical filament tau binding proteinThe FASEB Journal, 2005
- Methionine regulates copper/hydrogen peroxide oxidation products of AβJournal of Peptide Science, 2004
- Post-translational modifications of tau protein in Alzheimer’s diseaseJournal of Neural Transmission, 2004
- Analysis of α-Synuclein-associated Proteins by Quantitative ProteomicsPublished by Elsevier BV ,2004
- Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine OxidationJournal of Biological Chemistry, 2003
- Tau Polymerization: Role of the Amino TerminusBiochemistry, 2003
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- The microtubule binding domain of tau proteinNeuron, 1989